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Role of subnetworks mediated 
by TNFα , IL‑23/IL‑17 and IL‑15 
in a network involved 
in the pathogenesis of psoriasis
Rakesh Pandey1,8*, Yusur Al‑Nuaimi2, Rajiv Kumar Mishra3,9, Sarah K. Spurgeon4 & 
Marc Goodfellow1,5,6,7*
Psoriasis is a chronic inflammatory skin disease clinically characterized by the appearance of red 
colored, well‑demarcated plaques with thickened skin and with silvery scales. Recent studies have 
established the involvement of a complex signalling network of interactions between cytokines, 
immune cells and skin cells called keratinocytes. Keratinocytes form the cells of the outermost layer 
of the skin (epidermis). Visible plaques in psoriasis are developed due to the fast proliferation and 
unusual differentiation of keratinocyte cells. Despite that, the exact mechanism of the appearance 
of these plaques in the cytokine‑immune cell network is not clear. A mathematical model embodying 
interactions between key immune cells believed to be involved in psoriasis, keratinocytes and relevant 
cytokines has been developed. The complex network formed of these interactions poses several 
challenges. Here, we choose to study subnetworks of this complex network and initially focus on 
interactions involving TNFα , IL‑23/IL‑17, and IL‑15. These are chosen based on known evidence of their 
therapeutic efficacy. In addition, we explore the role of IL‑15 in the pathogenesis of psoriasis and its 
potential as a future drug target for a novel treatment option. We perform steady state analyses for 
these subnetworks and demonstrate that the interactions between cells, driven by cytokines could 
cause the emergence of a psoriasis state (hyper‑proliferation of keratinocytes) when levels of TNFα , 
IL‑23/IL‑17 or IL‑15 are increased. The model results explain and support the clinical potentiality of 
anti‑cytokine treatments. Interestingly, our results suggest different dynamic scenarios underpin the 
pathogenesis of psoriasis, depending upon the dominant cytokines of subnetworks. We observed that 
the increase in the level of IL‑23/IL‑17 and IL‑15 could lead to psoriasis via a bistable route, whereas 
an increase in the level of TNFα would lead to a monotonic and gradual disease progression. Further, 
we demonstrate how this insight, bistability, could be exploited to improve the current therapies and 
develop novel treatment strategies for psoriasis.
Psoriasis is a prevalent chronic inflammatory skin disease which affects people of all ages and  ethnicities1. 
Chronic plaque psoriasis (also known as psoriasis vulgaris) is the commonest form and occurs in 90% of  cases2. 
It has a characteristic appearance that consists of well demarcated, inflamed plaques covered with silvery-white 
scales. The outer-most layer of the human skin (epidermis) thickens in these lesions due to increased proliferation 
and abnormal differentiation of keratinocytes, which are the predominant cells of the epidermis. The severity of 
psoriasis can range from the involvement of small, isolated areas to covering the majority of patients’ skin. In the 
case of mild disease, topical treatments are prescribed whereas phototherapy (using ultraviolet light), systemic 
and biological therapies are used for moderate-to-severe cases. Although these therapies are often successful, 
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response varies from patient to patient, and it is therefore crucial to better understand why these treatments 
work in some cases and not others.
Psoriasis had previously been described as a primary disorder of keratinocyte proliferation and differentiation. 
However, advances in genetic and immunological techniques have led to improvements in our understanding 
of psoriasis, which is now widely recognised as a complex and multi-factorial, immune-mediated inflamma-
tory  disease3–5. Psoriasis can therefore be thought of as a multi-scale dynamic disease arising as a manifestation 
of the dysregulated interaction between keratinocytes and the immune system. Given this complexity and in 
order to understand how the disease state arises, research strategies involving experimental and mathematical 
modelling of these processes are  essential6. As such, several in vitro and in vivo models have been proposed to 
study its underlying  causes7 along with the use of in silico models to understand healthy and psoriatic epidermic 
growth. These in silico models can be classified into two groups: (1) agent-based8–12, and (2) ordinary differential 
equation (ODE)  based13–15. The agent based models could simulate the non-lesional and psoriatic keratinocyte 
compartment of the epidermis as well as the UVB (Ultraviolet B) intervention for plaque resolution. In this 
method, each cell is represented by a software agent and each agent has a rule set that determines the behavior. 
The rule set also determines the interaction of agents with their neighbours and that can be used to model the 
organisation of multicellular  aggregates8. An ODE model developed by Valeyev et al.13 considered interactions 
between immune cell populations based on their cytokine production profiles and informed the mechanism of 
inflammation in human skin. Mathematical models for the pathogenesis of psoriasis have been developed by Roy 
et al.14,15 involving the densities of immune cells and keratinocytes. They have considered the hyper-proliferation 
of keratinocytes as one of the precursors of psoriasis. Further, they demonstrated a method for stable control of 
the keratinocyte population using negative feedback. In a recent study, they have demonstrated the role of Th1 
and Th2 cells in the pathogenesis of psoriasis using an ODE based mathematical  model16.
In order to further our understanding of the role that immune cells and cytokines play in the pathogenesis 
of psoriasis, we recently synthesised current evidence into a mathematical model of the network of cytokine-
mediated interactions between key immune cells (T-cells and dendritic cells) and  keratinocytes18. The inclusion 
of keratinocytes was crucial to enable the diseased and healthy psoriasis phenotypes to be modelled. Within this 
framework, we demonstrated the existence of healthy and diseased states, as well as the potential for cytokines to 
behave as finite-time controllers of the state of the system. This model therefore offers the potential to advance 
our understanding of the mechanisms underlying the success or failure of biological treatments. A challenging 
task in terms of analysis, however, is the complexity of the system, as interactions between cells are mediated by 
many different cytokines.
To further our insight into this system here we identify specific cytokines those mediate subnetworks of the 
network formed of key immune cells and keratinocytes. Such subnetworks could be particularly important for 
governing system  dynamics19, but also allow a systematic analysis of how they may mediate transitions between 
healthy and psoriatic states. In particular, we focus on sub-networks mediated by cytokines TNFα , IL-17/IL-23 
axis and IL-15. Selection of TNFα and IL-17/IL-23 axis is inspired by biologics either approved by the FDA (Food 
and Drug Administration) or under clinical trials targeting  them20–22. However, to date there is no psoriasis 
treatment directly targeting IL-15. Indeed, evidence linking IL-15 to psoriasis pathogenesis is less abundant than 
the other cytokines considered above (though see, for  example23–25). Nevertheless, the interactions between cell 
types relevant for psoriasis that we identified do involve IL-15 and our research indicates that IL-15 links all 3 
cell types considered. It is therefore interesting to understand the role that it plays in regulating the dynamics of 
this network. In addition, the structure of the subnetwork mediated by IL-15 resembles the well known coher-
ent feed forward loop motif observed and analysed in the context of gene regulatory networks .We study the 
asymptotic behaviour of these subnetworks and demonstrate the potential for each of these cytokines to mediate 
transitions between healthy and psoriasis states. We find that increases in levels of TNFα and IL-23/IL-17 lead 
to a high keratinocyte state, which is in line with their inhibitors being used as treatments for psoriasis. Our 
analysis further suggests that these cytokines exhibit different dynamic routes to psoriasis. Hyper-proliferation 
of keratinocytes due to increases in the level of IL-23/IL-17 can occur via a bistable regime in which two steady 
state populations of keratinocytes is possible. A similar behaviour also occurs for the subnetwork involving 
cytokines IL-15. In contrast, the progression of psoriasis in the subnetwork formed by TNFα is found to occur 
without bistability, instead giving rise to a monotonic increase in the keratinocyte population. Due to bistability, 
we expect the possibility of a quicker disease progression mediated by IL-17/IL-23 and IL-15 than TNFα . Thus, 
we may observe a faster onset of recovery for biologics targeting IL-17/IL-23 and IL-15 in compared to TNFα 
inhibitors. These results are consistent with the observation that IL-17 inhibitors act quickly and efficiently than 
TNFα  inhibitors21,22,26. However, the better clinical response of IL-17 is not attributed to bistability yet. Further, 
we discuss the relevance of these findings for the future development of treatments for psoriasis.
Results
Dynamics of the subnetwork mediated by the TNFα. We first study the dynamics of the subnetwork 
that emerges due to interactions mediated by TNFα (Fig. 1B; Eq. 7). Although we have greatly reduced the com-
plexity of the system, six parameters remain which determine its dynamics.
The steady state behaviour of the subnetwork for varying model parameters is investigated using bifurca-
tion analysis techniques of dynamical systems and the result is shown in Fig. 2. We study the effect of varying 
parameters independently in the first instance, focussing on parameters that directly modulate the keratinocyte 
population (such as q), embody the cytokine effect ( b′TNF ) and the effect of changes in T-cell numbers ( ̄L ). We 
observe that an increase in the modulatory effect of TNFα i.e. high level of TNFα represented by b
′
TNF could lead 
to increase in the population of keratinocytes and therefore to psoriasis as the keratinocytes are observed to be 
hyper-proliferative in psoriatic  skin3,27,28. The keratinocyte population would also increase with increase in the 
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effective rate of migration of keratinocytes denoted by q. Also, psoriasis would develop when the strength of the 
modulatory effect of dendritic cells on other modelled cells is stronger than that of keratinocytes, represented by 
a large value of u (Fig. 2A). The large vale of u (= kDkK  ) suggests that the impact of the keratinocyte cell population on dendritic cells and its own population would be stronger than the impact of the dendritic cell population.
In contrast to the above, the keratinocyte population decreases with increase in the steady state population 
of T-cells ( ̄L ), Hill coefficient (n), and effective rate of migration of dendritic cells towards the lesion (p) (Fig. 2).
Based on the known mode of action of anti-TNF biologics, we use Fig. 2A to define healthy and psoriasis 
states. It is henceforth assumed that a value of K̄  above 4 is considered as a psoriasis state. In fact, a four-fold 
increase in the number of keratinocytes compared to healthy skin has been previously  suggested13. We observe 
a gradual and monotonic increase in keratinocytes therefore these results suggests that this subnetwork would 
lead to a gradual progression of psoriasis.
We extend this analysis by considering the interplay between b′TNF and the other parameters in Fig. 2B–F. 
Figure 2B demonstrates that decreasing the value of the Hill coefficient, n in Eq. (7), causes keratinocyte levels to 
have a higher sensitivity to increases in b′TNF . This sensitivity would also increase with increase in the effective rate 
of inward migration of keratinocytes (Fig. 2B) and the modulatory effect of the dendritic cell population being 
more effective than that of the keratinocyte population (Fig. 2C). Nonetheless, this sensitivity would be decreased 
by increasing the steady state level of T-cells ( ̄L ) and the inward effective rate of migration of the dendritic cell 
population (p) (Fig. 2E, F). Here, kD and kK are assumed to have the properties of a dissociation constant in a 
Hill function. These results suggest that the steepness in increase or decrease in the population of keratinocytes 
in response to varying level of TNFα could be modified by changing other model parameters. In other words, 
the sensitivity of the increase or decrease in the keratinocyte population to fluctuating level of TNFα would be 
determined by other model parameters.
Dynamics of the IL‑23 and IL‑17 mediated subnetwork. This subnetwork is mediated by the widely 
known “IL-23/IL-17” axis which has been extensively explored for developing a treatment for  psoriasis22,29,30. 
Figure 1.  (A) A schematic diagram explaining cytokine mediated interactions among the cell types 
predominantly implicated in psoriasis. Here, L denotes the population of T-cells and for simplicity a single pool 
is considered. The symbol D represents matured dendritic cells(DCs). Note that the primary role of immature 
DCs is in antigen detection, uptake and processing whereas mature DCs are believed to function in antigen 
presentation and cytokine  production17. The symbol K represents the population of keratinocytes. Arrows 
show an increase in population and lines with a bar end denote inhibition of the population. (B) A subnetwork 
of the network (A) involving only TNFα . (C) Cytokine IL-17 and IL-23 mediated subnetwork of the network. 
Here, a red colored arrow represents the net effect of the dendritic and T-cell population on keratinocytes. The 
question mark indicates the lack of clarity about this signal which could be either inducing or inhibiting. (D) 
The subnetwork involving cytokine IL-15 alone.
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This subnetwork is formed of two feedforward loops between dendritic and T-cells, the output of which deter-
mines the dynamics of the population of keratinocytes (Fig. 1C). Along-with studying the asymptotic behavior 
of this subnetwork, we wish to determine whether the net effect of the output of this axis on the population of 
keratinocytes is enhancing or inhibitory. We performed a steady state analysis of the subnetwork equations, 
accounting for either an activating (case 1) or inhibiting (case 2) effect of dendritic and T-cells on the population 
of keratinocytes (governed by Eqs. 9 and 11, respectively).
A steady state characteristic behavior of this subnetwork in case 1 is shown in Fig. 3 and Fig. S1A–L. Fig-
ure 3A suggests that the keratinocyte population increases with increase in the level of either of the cytokines, 
IL-23 and IL-17, represented by parameters b′IL23 and b
′
IL17 , respectively. However, the increase is more sensitive 
to changes in IL-17 compared to IL-23 (Fig. 3A) . The keratinocyte population also increases with increase in 
the parameters p, q and r representing the effective rate of migration of dendritic, keratinocytes and T-cells, 
respectively towards the lesion. Increases in the parameter kA and n (representing the effective dissociation 
constant and Hill coefficient, respectively for the combined effect of IL-23 and IL-17) leads to a decrease in the 
population of keratinocytes. Note that changes in the above mentioned parameters result in either increase or 
decrease in the population of keratinocytes but monotonically. Therefore, these results suggest that for some 
parameter combinations, changes in the model parameters could lead to a gradual increase or decrease in the 
keratinocyte population.
Interestingly, the changes in the modulatory effect of IL-23 ( b′IL23 ) or IL-17 ( b
′
IL17 ) could lead to a pair of 
saddle-node bifurcations, and hence a region of bistability (Fig. 3B,C) especially for n > 1 . The bistable region 
is bounded by the saddle node bifurcations, 74.5 < b′IL23 < 104.3 and 0.4 < b
′
IL17 < 25 for the given parameter 
combinations and denoted by LP in the figure. In fact, there is a large region of bistability in the two parameter 
spaces of n vs b′IL23 and n vs b
′
IL17 as depicted in Fig. 3D and Fig. S1K,L. In the bistable region, two stable and an 
unstable steady state, shown by the solid and dotted line in Fig. 3B,C, respectively coexist. The bifurcation points 
separate the system’s response into two distinct regions—low and high keratinocyte populations. The meaning 
of the bistability will be further explained in the next section and Fig. 5. Note that, there is ≈ 4 fold difference in 
the low and high keratinocyte levels similar to the previous subnetwork (Fig. 1B). Also the high and low level of 
keratinocytes correspond to a psoriatic (diseased) and healthy state, respectively.
Our analysis suggests that the increase in the population of keratinocytes in response to the increase in the 
level of IL-17 would be sensitive to the present level of IL-23 (Fig. 3E). In fact, if the present level of IL-23 is 
comparatively high then the changes in keratinocyte population would be more sensitive to the changes in the 
level of IL-17 (Fig. 3E). Similarly, the present level of IL-17 would determine the sensitivity of the increase in the 
population of keratinocytes in response to the increase in the level of IL-23 (Fig. 3F). Like in panel E of Fig. 3 , 
a high present level of IL-17 ensures comparatively high sensitivity of increases in keratinocytes, in response to 
changes in the level of IL-23.
The steady state behavior of the subnetwork in case 2 is shown in Fig. 4. As shown in Fig. 4A, in contrast to 
case 1, the population of keratinocytes decreases with an increase in the level of IL-17 ( b′IL17 ) and IL-23 ( b
′
IL23 ) as 
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Figure 2.  Steady state behavior of the subnetwork mediated by TNFα (Fig.1B). (A) Steady state response 
curve of the keratinocyte population for varying model parameters of the subnetwork. The “parameters” on 
the abscissa, represent b′TNF , p, q, n, L̄ , and u and the likely variation is shown by different coloured lines. (B–F) 
The response curve of the keratinocytes as a function of the varying level of TNFα can be refined and adjusted 
by changing other parameters. Effect of changes in parameters: Hill coefficient (n), u, q,L̄ , and p on the steady 
state response of keratinocyte population to varying b′TNF (level of TNFα ), respectively. The default parameters 
are: b′TNF = 1 , p = 0.01 day
−1 , q = 0.1 day−1 , L̄ = 0.1 , u = 10 , n = 1 , µK = 0.5 day−1 , and µD = 0.2 day−1 . The 
initial condition is K̄ = 4 and D̄ = 2 throughout.
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well as with increase in the effective rate of migration of the cell populations (represented by p, q, and r). How-
ever, the high sensitivity to changes in the level of IL-17 compared to that of in the level of IL-23, is preserved as 
the population of keratinocytes decreases faster with increase in IL-17. Therefore, our analysis suggests that the 
proliferation of keratinocytes would be more sensitive to changes in the level of IL-17 than to IL-23 (Figs. 3A, 
4A). Because of this, we argue that an IL-17 blocker could potentially be more effective than an IL-23 inhibitor.
The population of keratinocytes increases with increase in the parameter kA and n, which is opposite to what 
is observed in case 1. Therefore, the response to changes in the level of IL-17 and IL-23 in cases 1 and 2 are 
antagonist to each other (Figs. 3A, 4A) as expected.
In addition, compared to IL-17 and IL-23, the increase in the keratinocyte population is less sensitive to 
changes in the net population of dendritic and T-cells for small values of bnet (Fig. S1B, G). For large values of 
bnet , the keratinocyte population increases almost linearly (Fig. S1B,G). This highlights the multi-faceted impact 
of changes in the cytokine levels in comparison with the effects of direct changes in the cell population.
We observe that case 2 could also give rise to a region of bistability in response to the changes in the level of 
IL-17 and IL-23 (Fig. 4B,C). However, in this case, for low levels of IL-23 and IL-17 the population of keratino-
cytes would be very high which is opposite to the case 1. In this case too, the region of bistability is large (Fig. 4F, 
Fig. S2L–N).
As with case 1, the decrease in the population of keratinocytes in response to increase in the level of IL-17 is 
sensitive to the present levels of IL-23 (Fig. 4E). In fact, it decreases faster at high level of IL-23 in response to 
the increase in the level of IL-17. Similarly, the population of keratinocytes decreases faster if the present level of 
IL-17 is high in response to an increase in IL-23 (Fig. 4F). These results suggest that although, in case 2, the popu-
lation of keratinocytes decreases with increase in the level of IL-17 and IL-23, as opposed to case 1, the sensitivity 
of decrease (increase in case 1) would still be determined by the present level of IL-23 and IL-17, respectively.
Our analysis demonstrates that the net effect of the populations of dendritic and T-cells on keratinocytes 
would be activating to be consistent with the current knowledge about IL-17. The IL-17 family of cytokines have 
been suggested to be most relevant to the pathogenesis of psoriasis because of their action on keratinocytes 
and the increased level within psoriatic  lesions31,32. Also, higher serum and lesional levels of a member of this 
family, IL-17A, in psoriasis patients compared to controls have been reported which supports the role of IL-17 
A in this  disease31,33. In addition, the use of IL-17 blockade (ixekizumab) has shown a significant reduction in 
Figure 3.  A characteristic steady state functioning of the subnetwork mediated by “IL-23/IL-17” axis in 
case 1. (A) Steady state response curve of the keratinocyte population for changing model parameter values 
of the subnetwork (Fig. 1C). (B,C) Response of the keratinocyte population to changes in the level of IL-23 
and IL-17, represented by b′IL23 and b
′
IL17 , respectively could be non-graded and non-monotonic, in fact 
bistable. Dotted lines correspond to the unstable steady state bounded by saddle node bifurcations denoted 
by LP. (D) The separation of the two parameter spaces formed by n and the level of IL-23 in Monostable 
(green) and bistable (blue) regions. (E) The current level of IL-23 dependent sensitivity on the increase in the 
population of keratinocytes for varying level of IL-17. (F) The IL-17 level dependent sensitivity of the increase 
in the population of keratinocytes in response to increase in the level of IL-23. The default parameters are: 
b
′
IL23 = 1, b
′
IL17 = 0.01 , bnet = 5 , p = 0.01 day−1 , q = 0.1 day−1 , r = 0.01, n = 1, µL = 0.5 day−1 , µK = 0.5 
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Figure 4.  The signal response curve for the subnetwork mediated by IL-17 and IL-23 (Fig. 1C) in the case 2 
scenario. (A) Steady state population of keratinocytes for varying model parameters. (B) Bistable response of 
keratinocyte population for changes in the level of IL-17. (C) For parameter combinations as in Fig. 3, bistability 
would not be observed. However, changing b′IL17 = 10 , b
′
net = 1.6 and n = 2 could lead to a bistable behavior. 
(D) Effect of the present level of IL-23 on the steady state response of the keratinocyte population for changing 
levels of IL-17. (E) Modulatory effect of the present level of IL-17 on the steady state response of the keratinocyte 
population for varying levels of IL-23. (F) The separation of the two parameter space spanned by the level of 
IL-17 and the Hill coefficient (n) in monostable (green) and bistable (blue) regions. Model parameters as in 
Fig. 3 except in (C) where b′IL17 = 10 , b
′
net = 1.6 and n = 2.
Figure 5.  A signal response curve for the subnetwork involving cytokine IL-15 (Fig. 1D). (A) Changes in 
the stead state population of keratinocytes in response to changes in the model parameters. (B) The hyper-
proliferation of keratinocytes can occur via a bistable regime in response to varying level of IL-15. In that regime 
the steady state keratinocyte population can exist in two distinct states: low and high. The low steady state 
population corresponds to a healthy population and the higher one corresponds to a psoriatic state. (C) The 
separation of bistable (blue) and monostable (green) regions in the two parameter spaces formed by the level of 
IL-15 and Hill coefficient (n). (D–F) A demonstration of typical trajectories of the keratinocyte population in 
monostable and bistable regions. While the point “a” is in monostable region, the point “b” lies in the bistable 
region. The model parameters are: b′IL−15 = 4, v = 0.1, r = 0.01, q = 0.1, n = 1,µL = 0.5 and µK = 0.5 . The 
initial condition is L̄ = 2 and K̄ = 4.
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keratinocyte proliferation and infiltration of T-cells and dendritic cells into the dermis and epidermis compared 
to the  baseline34. Therefore, the hypothesis of case 1 is most likely in in vivo conditions.
Dynamics of the subnetwork involving IL‑15. This subnetwork is formed of a coherent feed-forward 
loop and self activation. Following the mathematical modelling frame work discussed above the population 
dynamics of this subnetwork (Fig. 1D) is governed by Eq. (14). The steady state response of the keratinocyte 
population to varying model parameters independently is shown in Fig. 5A. We observe that the increase in the 
level of IL-15, denoted by the large value of b′IL−15 would lead to increased keratinocyte population and there-
fore a psoriatic state. Similarly, increase in the parameter q and r representing the effective rate of migration of 
keratinocytes and T cells, respectively towards the lesion would result in psoriasis.
The keratinocyte population would also increase with increase in the parameter v(= kdkk ) which compares the strength of the effect caused by dendritic cells and keratinocytes on other modelled cell types (Fig. 5A). A 
large value of v denotes that the effect of dendritic cells on other modelled cell types should be stronger than that 
of the keratinocytes. The keratinocyte population would also increase with increase in the parameter n, defin-
ing the Hill coefficient characteristic (Fig. 5A). We analyse how other model parameters affect the steady-state 
response of the keratinocyte for varying levels of IL-15 (Fig. 5B, Fig. S3A–C). A steady state analysis of Eq. (14) 
shows that the population of keratinocytes could increase via a bistable regime (Fig. 5B). It also suggests that the 
subnetwork would not show bistable behavior if the Hill coefficient n < 3 (Fig. 5B). The exact steady state popula-
tion of K in the bistable regime could be determined by the initial condition i.e. initial population of T-cells and 
keratinocytes. As observed with the subnetworks, the high value of K corresponds to a psoriatic state whereas 
a low value represents a healthy state since the keratinocytes are observed to be hyper-proliferative in psoriatic 
 skin3,27,28. These results suggest that an increase in the intracellular IL-15 level could lead to a large increase in 
the keratinocyte population and therefore to a psoriatic state. The increase in the level of IL-15 could be caused 
by several internal and/or external factors.
Figure 5C,D suggest that this bistable phenomena is very robust as the system is bistable in a large region of 
the two parameter spaces. Examples of dynamics in the monostable and bistable region are shown in Fig. 5E,F. 
Note that in the bistable region, the system reaches two distinct steady states with the same parameter combina-
tion for different initial conditions.
In order to find the source of bistability in this subnetwork, we remove the auto activation of keratinocytes. 
It leads to the following modification to Eq. (13)












Here we observe that the subnetwork does not show bistability in the absence of the self activation of keratino-
cytes. This is not surprising as the presence of a positive feedback loop is a necessary condition for a reaction 
network to exhibit  bistability35–37. Therefore, our results suggest that the source of bistability in this subnetwork 
would be the self activation loop of keratinocytes.
A novel therapy for treating Psoriasis by exploiting bistability. The present study suggests that the 
subnetworks involving the IL-23/IL-17 axis and IL-15 cytokine could cause psoriasis via bistable regimes, we 
explore if this behavior can be exploited in order to find a new treatment option. Our approach is demonstrated 
for the subnetwork formed by IL-15.
In the model, an IL-15 level corresponds to a particular value of parameter b′IL15 . To mimic the treatment of 
employing an anti IL-15 drug, b′IL15 is decreased. Also, we assume that the absorption and dynamics of the drug 
is faster than the dynamics of this subnetwork, and therefore a rapid drop in b′IL15 is assumed following admin-
istration of anti IL-15 drugs. This drop is modelled by using an inverse rectangular pulse of the following form 
where t is in days. The time window (t1, t2) corresponds to the duration in which the signal S drops completely. 
The selection of time t1 depends on the dynamics of the subnetwork (and in turn also on the parameter combi-
nation), as the signal should fall only after the steady state is reached. The incorporation of an anti IL-15 signal 
S in the system modifies Eq. (14) as follows
This ODE system (Eq. 3) is solved for a parameter combination in which the subnetwork shows bistability (for 
example the parameter combination in Fig. 5B). The initial condition is chosen such that, eventually, the dynam-
ics of the subnetwork reaches a steady state where K̄ is high. One such initial condition ( ̄L = 2 and K̄ = 4 ) is 























1 t ∈ [0, t1] and t ≥ t2




















Scientific Reports |         (2021) 11:2204  | https://doi.org/10.1038/s41598-020-80507-7
www.nature.com/scientificreports/
steady state in 20 days (Fig. 5E,F). Therefore, an anti IL-15 signal is used after 20 days, which causes IL-15 to 
drop fully between 30 and 60 days (Fig. 6A,C). Our results suggest that the keratinocyte population would start 
decreasing as soon as the signal S drops (Fig. 6B,D). A comparison between Figs. 5E and 6D suggests that the 
keratinocyte population would eventually reach a lower steady state consistent with the initial condition L̄ = 0.2 
and K̄ = 0.2 . Interestingly, even if the signal bounces back to the previous level after 60 days, the system would 
remain in the lower steady state which corresponds to a psoriasis free state. These results demonstrate that anti 
IL-15 treatment could be a useful treatment for psoriasis. Indeed, IL-15 blockade in a xenograft mouse model 
has been shown to reduce the severity of  psoriasis38.
Discussion
In the present work, the asymptotic behavior of the three subnetworks has been investigated. Based on our 
numerical analysis, we suggest that increases in the level of cytokines IL-15, IL-17/IL-23 and TNFα would indeed 
lead to psoriasis but their routes would be different. In the case of a subnetwork involving only TNFα , the hyper-
proliferation of keratinocytes would occur monotonically while in subnetworks involving IL− 15 and IL-23/
IL-17 it could occur through a bistable regime. In the case of TNFα , psoriasis occurs with gradual increase in 
keratinocytes, therefore, we believe that an anti-TNFα drug should cure psoriasis gradually. In contrast, in the 
case of cytokines IL-17/IL-23 and IL-15 the increase in population could happen in an abrupt manner thanks 
to the bistability. These results are consistent with the observation that IL-17 inhibitors show quicker response 
and better efficacy compared to anti-TNFα  biologics21,22. However, based on this study we cannot attribute 
these observations to bistable behaviour although this warrants further investigation. In addition, here it is 
demonstrated that the bistable behavior could be an advantage for developing new treatments for psoriasis. 
The suggested treatment could be a strategy through which first the severity of the psoriasis could be lessened 
by appropriately perturbing the system even if the clearance of psoriasis is not achievable. Once the severity is 
reduced, medicines can be prescribed which would reduce or at least maintain the achieved low severity. Our 
results also suggests that targeting two or more cytokines at a time could be an effective strategy, which parallels 
movements to advocate bispecific  agents39. Interestingly, dual targets have previously been trialled for psoriasis 
(IL-17 with TNFα)40. Based, on our results we argue that targeting IL-15 and IL-17/IL-23 would be more effec-
tive than targeting TNFα.
One of the limitations of this work is that only three subnetworks of the full network described in Ref.18 are 
studied. Another limitation is, here, results are shown only for a small region of multidimensional parameter 
space. Further, while investigating the treatment of psoriasis via ‘anti-IL-15’ treatment only one type of signal 
was assumed to have perturbed the system. To overcome these limitations the model should be expanded upon 
in a number of ways in the future. Firstly, other important components for psoriasis pathogenesis should be 
Figure 6.  IL-15 signal and treatment of psoriasis using an anti IL-15 drug. (A,C) An exemplary IL-15 
signal before and after using an anti IL-15 drug. The signal has become an inverse rectangular pulse. The 
signal vanishes completely between the time interval 30–60 days and bounces back to the initial strength 
immediately after 60 days. (B) The dynamics of the keratinocyte population before and after using an 
anti IL-15 drug. The disease relapses after the effect of the drug vanishe. The model parameters are: 
b
′
IL−15 = 6, v = 0.1, r = 0.01, q = 0.2, n = 3,µL = 0.5 and µK = 0.5 . The default initial condition is: K̄ = 4 
and L̄ = 2 . (D) Dynamics of the subnetwork before and after applying the anti IL-15 signal shown in (A,C). 
Parameters are chosen such that the system could show bistable behavior (point b in two parameter region 
in Fig. 5D). This demonstrates that after the application of the signal the system would switch from one 
steady state (psoriatic) to another (healthy state) and remain there. The used model parameter values are: 
b
′
IL−15 = 3, v = 0.1, r = 0.01, q = 0.05, n = 3,µL = 0.5 and µK = 0.5 . The default initial condition is: K̄ = 4 
and L̄ = 2.
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incorporated. These would include key immune cells such as macrophages, neutrophils and natural killer cells. 
Additionally, future models should investigate other cytokines that are implicated in psoriasis, such as IL-22. In 
our model, for simplicity, IL-17 represents all members of its family. Future work should address the role of IL-17 
subtypes. Model results should also be compared with the available experimental data. In future, by exploring 
patient-specific models and predicting their response to treatments, one could aim for personalized medicine.
Methods
In18, we synthesised existing knowledge into a schematic of the cytokine-mediated feedback network between 
keratinocytes, T-cells and dendritic cells. This schematic is reproduced in Fig. 1A. In order to mediate a tractable 
analysis of the dynamics of this network, in the context of treatment for psoriasis, we highlight three sub-net-
works of interest, mediated by one or two cytokines (IL-23/IL-17, TNFα and IL-15) in Fig. 1B–D. The dynamics 
of these sub-networks is the focus of the current study.
The mathematical modelling framework. The population dynamics of the considered cell types is 
modelled using ordinary differential equations (ODEs) as proposed in our previous general model for psoriasis 
 pathogenesis18.
where ax represents a basal rate of increase in the cell population x due to migration or differentiation factors, 
which is assumed to be independent of the current population x. The third term ( µx ) represents the decay in cell 
population levels (for example apoptosis independent of modelled cytokines). The second term represents a net 
birth rate which encompasses the cytokine-mediated effects of (1) differentiation/maturation, (2) proliferation 
and (3) apoptosis. We assume a saturation in the birth rate, dependent upon the cell population (x) and therefore 
use either of following two forms, to account for enhancing or diminishing effects of cytokines: 
 (i) if bs increases with an increase in the cell population x
 (ii) if bs decreases with an increase in the cell population 
Here, bx represents the saturated rate of change due to change in the population x. The parameter kx can 
be interpreted as the fraction of the population x required to achieve half the maximal increase/decrease 
in x due to the population x. The parameter n is the Hill coefficient, which determines the slope of the 
function bs.
In the following sections we introduce specific forms of Eq. (4) for the three subnetworks of interest.
TNFα sub‑network model. Figure 1B details the interactions between cells driven by TNFα . Using the general 
system (Eq. 4), these interactions are modelled using the following set of ODEs:
where L, D and K denote the current population of T cells, matured dendritic cells and keratinocytes, respec-
tively. The parameter bTNFα represents the maximum rate of increase in D and K due to the effect of the cytokine 
TNFα which is secreted from all three types of cells. The parameter kD denotes the population of dendritic cells 
required for half of the maximum effect D can achieve on K or D. Similarly, kK (or kL ) represents the population 
of keratinocytes (or T-cells) required for half of the maximum effect K (or L) can have on D or K.
From Eq. (5), it is obvious that the dynamics of the T-cells is independent of the dynamics of the dendritic 
cells and keratinocytes. Therefore, a quasi-steady state scenario for T-cells can be assumed and the ODE system, 
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where L∗ = aL
µL
 represents the steady state population of T-cells.
In order to further reduce the complexity of this and subsequent systems, we non-dimensionalise these equa-
tions. Assuming that K̄ = Kkk  , L̄ =
L∗
kL
 and D̄ = DkD  , the Eq. (6) can be represented by the dimensionless system





, q = aKkK  , and u =
kD
kK
IL‑23/IL‑17 sub‑network model. The cytokines IL-23 and IL-17 are currently used as targets for the treatment of 
 psoriasis20–22, and are therefore crucial components of our study. Figure 1A,C demonstrate that these cytokines 
form a feedback loop between dendritic cells and T-cells, but that there is no direct link to keratinocytes. Rather, 
the effect on keratinocytes is mediated by a network of connections involving other cytokines. In order to sim-
plify this scenario, we postulate a net effect of the IL-23/IL-17 axis on the keratinocyte populations. We consider 
that this net effect can either be activating or inhibiting, which gives rise to the following two cases:
Case (1): The net effect of D and L on K is activating
where A = D + L . L, D and K represent the population of modelled cells as for the previous subnetworks. Also, 
parameters bIL23 , bIL17 and bnet can be defined as for the corresponding terms in the previous subnetworks. The 
dimensionless form of Eq. (8) becomes
where L̄ = LkL  , D̄ =
D
kD













 and b′net =
bnet
kK
 . Parameters p 
and q, are defined same as in the previous subnetwork.
Case (2): The net effect of D and L on K is inhibitory. The population dynamics of the subnetwork is
where A = D + L . Other terms have the same meaning as in case (1). The dimensionless representation is
where L̄ = LkL , D̄ =
D
kD




IL17 , and 
′
net are defined same as in Case (1).
IL‑15 sub‑network model. IL-15 arises as an interesting cytokine as it mediates self-activation of keratinocytes 
(Fig. 1A). In addition, it promotes the production of cytokines such as IFN-γ , TNFα and IL-17 and therefore a 
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where L, D and K have the same meaning as in the previous subnetworks. The parameter bIL−15 represents the 
maximum rate of increase in T-cells and keratinocyte population due to changes in the modelled cell types; it 
reflects the effect of changing the level of IL-15. Note that changes in D and K will lead to changes in the level 
of IL-15 as it is secreted from D and K. The parameter kK can be described as the population of keratinocytes 
required for half of the maximum effect K can achieve on K or L. Similarly, kD can be defined as the population 
of dendritic cells required for half of the maximum effect D can have on L or K.
In Eq. (12), the dynamics of the dendritic cells is independent of the dynamics of the T-cells and keratinocytes. 
Therefore, a quasi-steady state scenario is assumed for dendritic cells and the ODE system (Eq. 12) will be largely 










)n . The corresponding dimensionless system is given by
where K̄ = KkK  and L̄ =
L
kL
 are dimensionless quantities and denote the relative population of keratinocytes and 






, v = kKkL  . Parameters q and r are defined same as in case of subnetwork involving TNFα.
Model parameters. The parameters of the system, and their default values are given in Table 1. The rate of 
apoptosis of T-cells ( µL ) has been estimated as 0.5 day−1 during their response to Lymphocytic Choriomenin-
gitis  Virus41. The rate of apoptosis of cutaneous dendritic cells ( µD ) has been observed to be approximately 0.2 
day−142. The rate of apoptosis of keratinocytes ( µK ) is unknown therefore given these two estimates, we choose 
a similar value, 0.5 day−1 , for that of keratinocytes.
In the subsequent section, we use the dynamics of the TNFα subnetwork to determine further parameters, 
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The datasets generated for this study can be found in the manuscript and supplementary Data.
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